Nebenwirkungen · Sitagliptin / Metformin hydrochloride Sun
Sitagliptin/Metformin hydrochloride SUN 50 mg/850 mg film-coated tablets Sitagliptin/Metformin hydrochloride SUN 50 mg/1 000 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 9
HOS-149431 · Präparat HOS-100052
There have been no therapeutic clinical studies conducted with sitagliptin/metformin hydrochloride tablets however bioequivalence of sitagliptin/metformin hydrochloride with co-administered sitagliptin and metformin has been demonstrated (see section 5.2). Serious adverse reactions including pancreatitis and hypersensitivity reactions have been reported. Hypoglycaemia has been reported in combination with sulphonylurea (13.8 %) and insulin (10.9 %).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-06T12:11:00Z · SHA-256 fd7e3c6c3895b7e664b95bd3e0199493082d8eb279c262d7cecdfbfc68d7c194 · Passage 6d180cc731127728f7c2157dc3dbf99f061f01b2250f18889fdcc513b9af4378 · Zeichen 31–484 im Abschnitt